Merck's Keytruda patient program has played into the immuno-oncology drug's success. (Merck) Merck celebrates the fifth anniversary of immunotherapy Keytruda this month. And central to its success has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results